At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparison of Two Forms of Intensive Voice Treatment for Parkinson's Disease
In Brief
A clinical study evaluating Lee Silverman Voice Treatment, SpeechVive, and 1 other intervention for Idiopathic Parkinson Disease. Completed, enrolled 36 participants across 2 sites.
Detailed Summary
This study addresses several issues related to the clinical management of speech and voice disorders associated with Parkinson's disease. Two behavioral treatment programs, Lee Silverman Voice Treatment and SpeechVive, are assessed in their ability to improve communication in persons with Parkinson's disease.
Study Details
Timeline
Interventions
Persons with Parkinson's disease receive sixteen hours of voice treatment over a four week period. Participants will practice the vocal exercises at home for an additional four weeks.
Persons with Parkinson's disease wear the SpeechVive device several hours a day over an eight week period during opportunities for communication.
Persons assigned to the non-treatment control group will not participate in voice treatment.